Aegon's H1 2026 results are less important to UK advisers and platform users than the transaction sitting alongside them. In April 2026, Aegon agreed to sell Aegon UK to Standard Life for total consideration of £2.0 billion - comprising a 15.3% stake in Standard Life and £750 million in cash.
The deal is expected to close around year-end 2026, subject to regulatory approval. When it does, Aegon UK will become part of the UK's largest retirement savings and income provider, with combined managed assets of £480 billion, according to Standard Life CEO Andy Briggs at the time of the announcement.
The group numbers provide the backdrop: operating result of EUR 804 million in H1 2026, up 9% year on year. Net result of EUR 608 million, broadly stable. Operating capital generation grew 27% to EUR 416 million. The interim dividend was raised 11% to EUR 0.21 per share. Aegon CEO Lard Friese confirmed the group is on track to meet or exceed all Group financial ambitions for 2026.
The FCA's change of control approval process will require Aegon and Standard Life to submit a transition plan covering how policyholders and platform users will be protected during and after the ownership transfer. That documentation will include adviser-facing transition arrangements. Advisers should not wait for it to be volunteered - they should be requesting sight of the adviser-relevant sections of that plan from their Aegon and Standard Life account contacts now, before the approval process concludes and before decisions are made that advisers will have less ability to influence.
The specific questions worth raising: will Aegon's adviser platform continue as a distinct proposition or will it migrate to a Standard Life platform over time, and if so over what timeline? What happens to client data, investment model portfolios, and existing drawdown arrangements during the transition? How will the combined business handle advisers who currently use both the Aegon and Standard Life platforms? What are the terms for client assets that need to move between platforms?
These are not hypothetical concerns. Standard Life operates two existing adviser platforms - Standard Life Wrap and Elevate - and has experience managing platform migrations. But each migration is specific to the systems, client profiles, and adviser arrangements involved. The earlier advisers engage on these questions, the more influence they have over how their clients' transitions are managed.
What is not in question is financial security. The Solvency UK ratio of Scottish Equitable plc - the primary UK insurance entity - remains above its operating level. Until the transaction closes, Aegon UK continues to serve advisers and their clients with no change to products, platforms, or service standards.
Aegon Asset Management is not part of the Standard Life sale. Following completion, Aegon AM will continue as an asset management partner to the combined Standard Life/Aegon UK business. In the UK, Aegon AM manages fixed income strategies through its Edinburgh office, including its liability-driven investment capabilities, responsible investment strategies, and a range of fixed income and multi-asset funds available through the Aegon platform. For advisers and Discretionary Fund Managers using Aegon AM fund ranges, the investment management relationship continues regardless of the platform transaction.
Aegon also announced on August 20 that CFO Duncan Russell will step down and leave the company in April 2027, in connection with the planned US relocation. A successor search has been initiated. This is managed succession rather than an unexpected departure: Russell confirmed he will remain "fully committed to supporting an orderly transition," and the April 2027 timeline provides significant runway. For UK advisers, the CFO transition is primarily a corporate governance development. It reinforces that the redomiciliation is proceeding at pace, but it carries no operational implications for Aegon UK or the Standard Life transaction timeline.
Friese's tribute to Russell - crediting him with "strengthening our financial foundations and positioning the company for long-term success" - reflects a CFO departure structured around the US relocation rather than any concern about the group's financial position.
Because of Aegon's accounting policies, Aegon UK no longer contributes to the group's operating result or operating capital generation from H1 2026. Its IFRS result is now reported under "Other income/(charges)" rather than the operating line. This is why the group free cash flow comparison of EUR 392 million for H1 2026 versus EUR 442 million in H1 2025 looks lower despite strong underlying group performance. The UK exclusion from the operating line accounts for the difference. This is an accounting presentation change, not a deterioration in either the UK business or the group.
The Standard Life transaction is the consequence of Aegon's strategic pivot to the US. The group selected New York City as its future head office location, with a planned redomiciliation targeting completion by January 1, 2028, at which point the holding company will be renamed Transamerica Inc. An Extraordinary General Meeting is targeted for October 8, 2026 to seek shareholder approval.
In the US, Transamerica delivered individual life sales growth of 54% in H1 2026, fuelled by the instant decision market, and World Financial Group surpassed 100,000 licensed agents. The group's capital generation and growth are increasingly US-anchored, which is the strategic context for why selling Aegon UK to a strong domestic owner makes sense for both parties.
For UK advisers, the practical message remains the same: Aegon UK is being transferred to stronger UK-focused ownership, not wound down or hollowed out. Standard Life is acquiring it precisely because of the value in the platform, the client base, and the Workplace proposition. The questions worth asking now are about how advisers' practices and their clients' assets will be managed through the transition - and the time to ask them is before completion, not after.
Group operating result EUR 804 million (+9%), operating capital generation EUR 416 million (+27%), free cash flow EUR 392 million. Interim dividend raised 11% to EUR 0.21 per share. H2 2026 share buyback increased by EUR 150 million to a total of EUR 350 million. Cash Capital at Holding of EUR 1.7 billion. Q3 results are due November 2026.
